High-throughput analysis of hematopoietic stem cell engraftment after intravenous and intracerebroventricular dosing-Reference-Cited by-同舟云学术

High-throughput analysis of hematopoietic stem cell engraftment after intravenous and intracerebroventricular dosing

Published:2022-10 Issue:10 Volume:30 Page:3209-3225
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Plasschaert Robert N.,DeAndrade Mark P.,Hull Fritz,Nguyen Quoc,Peterson Tara,Yan Aimin,Loperfido Mariana,Baricordi Cristina,Barbarossa Luigi,Yoon John K.,Dogan Yildirim,Unnisa Zeenath,Schindler Jeffrey W.,van Til Niek P.,Biasco Luca,Mason Chris

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference61 articles.

1. Gene therapy using haematopoietic stem and progenitor cells;Ferrari;Nat. Rev. Genet.,2021

2. Hematopoietic stem cell gene therapy: progress and lessons learned;Morgan;Cell Stem Cell,2017

3. Gene therapy comes of age;Dunbar;Science,2018

4. The transformative potential of HSC gene therapy as a genetic medicine;Sagoo;Gene Ther.,2021

5. Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency;De Ravin;Sci. Transl. Med.,2016

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic efficacy of intracerebral hematopoietic stem cell gene therapy in an Alzheimer’s disease mouse model;Nature Communications;2024-09-13

2. Novel strategies in Parkinson’s disease treatment: a review;Frontiers in Molecular Neuroscience;2024-08-09

3. CNS-wide repopulation by hematopoietic-derived microglia-like cells corrects progranulin deficiency in mice;Nature Communications;2024-07-05

4. Exploring the Significance of Microglial Phenotypes and Morphological Diversity in Neuroinflammation and Neurodegenerative Diseases: From Mechanisms to Potential Therapeutic Targets;Immunological Investigations;2024-06-05

5. TALEN-mediated intron editing of HSPCs enables transgene expression restricted to the myeloid lineage;Molecular Therapy;2024-06